CT-Based 2.5D Deep Learning-Multi-Instance Learning for Predicting Early Recurrence of Hepatocellular Carcinoma and Correlating with Recurrence-Related Pathological Indicators

基于CT的2.5D深度学习-多示例学习预测肝细胞癌早期复发并与复发相关病理指标进行关联

阅读:1

Abstract

PURPOSE: This study aims to evaluate the advantages of the 2.5D deep learning-multi-instance learning (2.5D DL-MIL) model, based on CT arterial phase images, in predicting early recurrence (ER) of hepatocellular carcinoma (HCC) and examining the biological significance of MIL features. PATIENTS AND METHODS: A total of 191 HCC patients were retrospectively included and categorized into ER (n=79) and non-early recurrence (NER, n=112) groups based on postoperative follow-up results. The patients were randomly divided to the training set (n=133) and validation set (n=58) in a 7:3 ratio. The predictive capabilities of the 2.5D DL-MIL model, Radiomics model, and Clinical model for ER of HCC were constructed and compared using CT arterial phase and clinical data. SHAP analysis was used to evaluate the contribution of MIL features in the model, and further analysis was conducted on the correlation between MIL features and microvascular invasion (MVI), Ki-67 expression, and pathological grading. RESULTS: The area under the curve (AUC) for the 2.5D DL-MIL model in the validation set was 0.840, surpassing that of the Radiomics model (AUC = 0.678, P = 0.047) and the Clinical model (AUC = 0.598, P = 0.009). Decision curve analyses indicated superior clinical utility for the 2.5D DL-MIL model. SHAP analysis revealed that bag-of-words features (eg, BoW_02 and BoW_09) were key contributors to the 2.5D DL-MIL model. Correlation analysis demonstrated that BoW_01, BoW_02, BoW_09, and BoW_1 were significantly correlated with MVI grade and Ki-67 expression (P < 0.05). CONCLUSION: The 2.5D DL-MIL model demonstrates significant value in predicting ER of HCC, with its MIL features exhibiting strong associations with tumor invasiveness and proliferative activity.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。